Typologie d'actualités: CBM

Conference – Exomars Mission: Life on the Red Planet – September 5th, 2019, Orléans

Conference - Exomars Mission: Life on the Red Planet - September 5th, 2019, Orléans

Given the success of the general public conference of Dr. Michel Viso, of the French Space Agency (CNES), a new presentation will take place

Thursday, September 5, 2019 at 18:00 at the Dupanloup Hotel, rue Dupanloup, 45000 Orléans.

With for the first time in France: Exhibition of the real size model of the robot Rosalind Franklin!

Free admission but limited places!

Conférence soutenue par L’ESA, le CNES, le CNRS (l’OSUC, le CBM, le LPC2E), l’Université d’Orléans, LOIRE&ORLÉANS ÉCO, la Région Centre.

Conference – Exomars mission : life on the red planet – September 3rd, Orléans

Public conference of Dr. Michel Viso, of the French Space Agency (CNES) will take place on

Tuesday, September 3rd, 2019 at 18:30 at the Dupanloup Hotel, rue Dupanloup, 45000 Orleans.

With for the first time in France: Exhibition of the real size model of the robot Rosalind Franklin!

Free entry but limited places!

Conference supported by ESA, CNES, CNRS (OSUC, CBM, LPC2E), University of Orléans, LOIRE & ORLÉANS ECO, Central Region.

A CBM project winner of the CNRS premature program

This project entitled "Preclinical Validation of LIMK Inhibitors in Cancer" will receive specific financial support. It is led by Hélène Benedetti, a researcher at the Center for Molecular Biophysics (CBM), and Sylvain Routier, a researcher at the Institute of Organic and Analytical Chemistry (ICOA). Its goal is to determine the efficacy of inhibitors, protein kinases LIMKs, new therapeutic targets particularly interesting to treat cancers for which existing therapies are ineffective. Prematuration will make it possible to characterize the cellular effect of these compounds and to determine their pharmacokinetic properties with a view to performing in vivo tests on three cancer models.

New models to predict and study the effects of cosmetic compounds

Evaluating the activity of compounds on the skin and understanding their mechanisms of action have become unavoidable steps to select and develop a dermocosmetic product. Since the ban on the use of animals in the cosmetic field, many "models" have been  developed, especially with recent advances in research in skin biology and computer science.

The book "Modèles pour l'évaluation des produits cosmétiques, de la molécule à l'humain", coordinated by Catherine Grillon, Leader of the Skin Biology Group at CBM, and Marek Haftek of the Laboratory of Tissue Biology and Therapeutic Engineering de Lyon, gives an overview of all the models used to evaluate the activity of dermocosmetic compounds, with their advantages, disadvantages and limitations. This book, edited by Cosmetic Valley Editions, brings together academic and industrial researchers, all specialists in their field, ranging from in silico prediction to in vivo evaluations, to all in vitro cell models, from the simplest to the most complex.